Telo Return On Assets from 2010 to 2024
| TELO Stock | CAD 0.11 0.01 8.33% |
Return On Assets | First Reported 2010-12-31 | Previous Quarter (2.81) | Current Value (0.12) | Quarterly Volatility 2.83461259 |
Check Telo Genomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telo Genomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 54.5 K, Selling General Administrative of 1.6 M or Other Operating Expenses of 2.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.0. Telo financial statements analysis is a perfect complement when working with Telo Genomics Valuation or Volatility modules.
Telo | Return On Assets |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.